Biomerics’ new Metal Injection Molding operation
Vertically integrated medical device contract manufacturer, Biomerics, Salt Lake City, USA, has opened a new Metal Injection Molding (MIM) facility, including a new Centre of Excellence.
By combining MIM with its other micro metals processing capabilities, Biomerics’ vertically integrated Micro Metals Division is now able to offer a full range of highly specialised, complex interventional medical devices and components. This suite of offerings includes the intricate components used in surgical robotics and minimally invasive surgical device applications.
TRUSTED BY INDUSTRY’S BIGGEST NAMES
Discover how we help leading brands shape the industry conversation
| Contact us |
“This investment in MIM reflects our thirty-year pursuit of innovation and manufacturing excellence,” stated Travis Sessions, Chief Executive Officer of Biomerics. “I’m thrilled to see our vertical integration on full display throughout our growing global operations, particularly in our Micro Metals Division. This investment also says a lot about the performance of our growing metals teams, the markets we manufacture for and our commitment to delivering the latest innovations in the medical device manufacturing industry. Our new Metal Injection Molding Center of Excellence will continue to fuel our growth with best-in-class speed-to-market capabilities.”
Metal Injection Molding is a proven technology that is routinely used for medical device manufacturing, capable of producing high-volume, highly repeatable runs of metal components requiring complex geometries, tight tolerances and demanding performance. It is able to overcome the design limitations of other metal fabrication processes and can produce extremely thin-walled, unique-shaped and micro-sized components.
The company stated that the high production efficiency of MIM lowers operational costs while consistently producing high-quality parts. MIM is also an ideal process for components that need to maintain the high-performance mechanical properties of metals, such as high density, homogeneous microstructure, corrosion resistance, magnetic permeability or hermetic sealing functionality. Unlike other metal casting processes, MIM maintains the strength of the wrought metal and achieves 95-99% theoretical density.
“Metal Injection Molding is a valuable enhancement to our metals manufacturing capabilities,” Arun Mohan, president of Biomerics’ Micro Metals Division. “Investing in innovative manufacturing technologies like MIM enables us to better serve our global customers. This exciting addition reflects our ongoing commitment to providing best-in-class services and capabilities that meet the evolving design and manufacturing needs of our partners.”
